{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2021:RCJEMKMQPQPG3HVELOWJGTJMVC","short_pith_number":"pith:RCJEMKMQ","schema_version":"1.0","canonical_sha256":"88924629907c1e6d9ea45bac934d2ca8b6f3ad1bdb0d0568d98bc50723ea02f7","source":{"kind":"arxiv","id":"2103.15065","version":1},"attestation_state":"computed","paper":{"title":"Possible Contexts of Use for In Silico trials methodologies: a consensus-based review","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"","cross_cats":["q-bio.QM"],"primary_cat":"physics.bio-ph","authors_text":"Alexander Kulesza, Axel Loewe, Cecile F. Rousseau, Cristina Curreli, Emmanuelle M. Voisin, Eulalie Courcelles, Francesco Pappalardo, Giulia Russo, Liesbet Geris, Luca Emili, Marc Horner, Marco Viceconti, Maria Cristina Jori, Markus Reiterer, Michael Neidlin, Nele Famaey, Payman Afshari, Simon J. Sonntag","submitted_at":"2021-03-28T06:48:03Z","abstract_excerpt":"The term \"In Silico Trial\" indicates the use of computer modelling and simulation to evaluate the safety and efficacy of a medical product, whether a drug, a medical device, a diagnostic product or an advanced therapy medicinal product. Predictive models are positioned as new methodologies for the development and the regulatory evaluation of medical products. New methodologies are qualified by regulators such as FDA and EMA through formal processes, where a first step is the definition of the Context of Use (CoU), which is a concise description of how the new methodology is intended to be used"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2103.15065","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"physics.bio-ph","submitted_at":"2021-03-28T06:48:03Z","cross_cats_sorted":["q-bio.QM"],"title_canon_sha256":"16f23b82fafb85b27aa416c5d999c4a5245b9af9dddc11fe06a7a9d4a6c4b233","abstract_canon_sha256":"c241deac91b10e24810099e0850417dd49c078542f46f5289d55ea6f46db7d4a"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T03:07:47.974590Z","signature_b64":"mzuBvBDJqaJ+PnCAFKO3r1SkvL2iBNh1cUfQxIgnz7Cs/DvJrk/uqb8KxDSEaa6gEMYfOtHA8LODmKEDk2uZBw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"88924629907c1e6d9ea45bac934d2ca8b6f3ad1bdb0d0568d98bc50723ea02f7","last_reissued_at":"2026-07-05T03:07:47.974107Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T03:07:47.974107Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Possible Contexts of Use for In Silico trials methodologies: a consensus-based review","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"","cross_cats":["q-bio.QM"],"primary_cat":"physics.bio-ph","authors_text":"Alexander Kulesza, Axel Loewe, Cecile F. Rousseau, Cristina Curreli, Emmanuelle M. Voisin, Eulalie Courcelles, Francesco Pappalardo, Giulia Russo, Liesbet Geris, Luca Emili, Marc Horner, Marco Viceconti, Maria Cristina Jori, Markus Reiterer, Michael Neidlin, Nele Famaey, Payman Afshari, Simon J. Sonntag","submitted_at":"2021-03-28T06:48:03Z","abstract_excerpt":"The term \"In Silico Trial\" indicates the use of computer modelling and simulation to evaluate the safety and efficacy of a medical product, whether a drug, a medical device, a diagnostic product or an advanced therapy medicinal product. Predictive models are positioned as new methodologies for the development and the regulatory evaluation of medical products. New methodologies are qualified by regulators such as FDA and EMA through formal processes, where a first step is the definition of the Context of Use (CoU), which is a concise description of how the new methodology is intended to be used"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2103.15065","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2103.15065/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2103.15065","created_at":"2026-07-05T03:07:47.974161+00:00"},{"alias_kind":"arxiv_version","alias_value":"2103.15065v1","created_at":"2026-07-05T03:07:47.974161+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2103.15065","created_at":"2026-07-05T03:07:47.974161+00:00"},{"alias_kind":"pith_short_12","alias_value":"RCJEMKMQPQPG","created_at":"2026-07-05T03:07:47.974161+00:00"},{"alias_kind":"pith_short_16","alias_value":"RCJEMKMQPQPG3HVE","created_at":"2026-07-05T03:07:47.974161+00:00"},{"alias_kind":"pith_short_8","alias_value":"RCJEMKMQ","created_at":"2026-07-05T03:07:47.974161+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC","json":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC.json","graph_json":"https://pith.science/api/pith-number/RCJEMKMQPQPG3HVELOWJGTJMVC/graph.json","events_json":"https://pith.science/api/pith-number/RCJEMKMQPQPG3HVELOWJGTJMVC/events.json","paper":"https://pith.science/paper/RCJEMKMQ"},"agent_actions":{"view_html":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC","download_json":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC.json","view_paper":"https://pith.science/paper/RCJEMKMQ","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2103.15065&json=true","fetch_graph":"https://pith.science/api/pith-number/RCJEMKMQPQPG3HVELOWJGTJMVC/graph.json","fetch_events":"https://pith.science/api/pith-number/RCJEMKMQPQPG3HVELOWJGTJMVC/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC/action/timestamp_anchor","attest_storage":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC/action/storage_attestation","attest_author":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC/action/author_attestation","sign_citation":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC/action/citation_signature","submit_replication":"https://pith.science/pith/RCJEMKMQPQPG3HVELOWJGTJMVC/action/replication_record"}},"created_at":"2026-07-05T03:07:47.974161+00:00","updated_at":"2026-07-05T03:07:47.974161+00:00"}